Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1996-01

AUTHORS

RW Boyle, J Rousseau, SV Kudrevich, MOK Obochi, JE van Lier

ABSTRACT

Hexadecafluorinated zinc phthalocyanine (ZnPcF16), an analogue of zinc phthalocyanine (ZnPc) in which all hydrogen atoms have been substituted by fluorine, was prepared as a single isomeric product via the condensation of tetrafluorophthalonitrile with zinc acetate. Fluorination renders the ZnPc soluble in most common solvents. The photodynamic properties and pharmacokinetics of the ZnPcF16 were evaluated in EMT-6 tumour-bearing Balb/c mice using 65Zn-radiolabelled analogues. Both dyes, administered i.v. at 1 mumol kg-1 as Cremophor emulsions, revealed good tumour uptake [approximately 8-9 per cent of the injected dose per g tissue (%IDg-1)] at 24 h post injection (p.i.), with the fluorinated dye reaching higher concentrations (approximately 11%IDg-1) at 48 h p.i. and subsequently higher tumour-blood ratios due to rapid blood clearance. ZnPcF16 at a dose of 5 mumol kg-1 (4.3 mg kg-1) induced complete tumour regression after phototherapy (24 h p.i., 650-700 nm band, 360 J cm-2, 200 mW cm-1). At a dose of 2 mumol kg-1 and phototherapy at 24 h p.i., the tumour volume doubling time increased to 11 days vs 6 days for the control tumours. A similar tumour growth delay was observed when phototherapy was conducted at 48 h or 72 h after dye injection implying that tumour response correlates with tumour dye concentrations rather than serum concentrations. As a result of its low solubility, the administered dose of ZnPc was limited to 1 mumol kg-1 and at this drug level significant tumour response was only observed when the dye was solubilised as the pyridinium salt. Isolation of the neoplastic cells after in vivo dye administration and in vitro exposure to red light followed by a colony formation assay showed that the ZnPcF16 exhibited a 1-2 order of magnitude higher potential for direct cell killing as compared with Photofrin and about a five times lower efficiency than ZnPc. However, all three photosensitisers induced complete occlusion of tumour vasculature immediately after PDT, suggesting that tumour regression mainly resulted from vascular stasis. The ZnPcF16 offers several advantages over ZnPc for clinical applications, including improved solubility in most solvents, resulting in facilitated drug formation, favourable pharmacokinetics as well as the potential use in fluorine magnetic resonance (F-MR) imaging. More... »

PAGES

49-53

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1996.9

DOI

http://dx.doi.org/10.1038/bjc.1996.9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028994188

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8554982


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Emulsions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organometallic Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Photochemotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Photosensitizing Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyethylene Glycols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Zinc Radioisotopes", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "MRC Group in the Radiation Sciences, Faculty of Medicine, Universit\u00e9 de Sherbrooke, Qu\u00e9bec, Canada", 
          "id": "http://www.grid.ac/institutes/grid.86715.3d", 
          "name": [
            "MRC Group in the Radiation Sciences, Faculty of Medicine, Universit\u00e9 de Sherbrooke, Qu\u00e9bec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boyle", 
        "givenName": "RW", 
        "id": "sg:person.01270352613.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270352613.45"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Rousseau", 
        "givenName": "J", 
        "id": "sg:person.01067576325.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067576325.99"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Kudrevich", 
        "givenName": "SV", 
        "id": "sg:person.012347733603.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012347733603.90"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Obochi", 
        "givenName": "MOK", 
        "type": "Person"
      }, 
      {
        "familyName": "van Lier", 
        "givenName": "JE", 
        "id": "sg:person.0707506374.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707506374.64"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1990.189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050177334", 
          "https://doi.org/10.1038/bjc.1990.189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/279679a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047841974", 
          "https://doi.org/10.1038/279679a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01002528", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010380021", 
          "https://doi.org/10.1007/bf01002528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1990.89", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015534457", 
          "https://doi.org/10.1038/bjc.1990.89"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1987.247", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052506826", 
          "https://doi.org/10.1038/bjc.1987.247"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1996-01", 
    "datePublishedReg": "1996-01-01", 
    "description": "Hexadecafluorinated zinc phthalocyanine (ZnPcF16), an analogue of zinc phthalocyanine (ZnPc) in which all hydrogen atoms have been substituted by fluorine, was prepared as a single isomeric product via the condensation of tetrafluorophthalonitrile with zinc acetate. Fluorination renders the ZnPc soluble in most common solvents. The photodynamic properties and pharmacokinetics of the ZnPcF16 were evaluated in EMT-6 tumour-bearing Balb/c mice using 65Zn-radiolabelled analogues. Both dyes, administered i.v. at 1 mumol kg-1 as Cremophor emulsions, revealed good tumour uptake [approximately 8-9 per cent of the injected dose per g tissue (%IDg-1)] at 24 h post injection (p.i.), with the fluorinated dye reaching higher concentrations (approximately 11%IDg-1) at 48 h p.i. and subsequently higher tumour-blood ratios due to rapid blood clearance. ZnPcF16 at a dose of 5 mumol kg-1 (4.3 mg kg-1) induced complete tumour regression after phototherapy (24 h p.i., 650-700 nm band, 360 J cm-2, 200 mW cm-1). At a dose of 2 mumol kg-1 and phototherapy at 24 h p.i., the tumour volume doubling time increased to 11 days vs 6 days for the control tumours. A similar tumour growth delay was observed when phototherapy was conducted at 48 h or 72 h after dye injection implying that tumour response correlates with tumour dye concentrations rather than serum concentrations. As a result of its low solubility, the administered dose of ZnPc was limited to 1 mumol kg-1 and at this drug level significant tumour response was only observed when the dye was solubilised as the pyridinium salt. Isolation of the neoplastic cells after in vivo dye administration and in vitro exposure to red light followed by a colony formation assay showed that the ZnPcF16 exhibited a 1-2 order of magnitude higher potential for direct cell killing as compared with Photofrin and about a five times lower efficiency than ZnPc. However, all three photosensitisers induced complete occlusion of tumour vasculature immediately after PDT, suggesting that tumour regression mainly resulted from vascular stasis. The ZnPcF16 offers several advantages over ZnPc for clinical applications, including improved solubility in most solvents, resulting in facilitated drug formation, favourable pharmacokinetics as well as the potential use in fluorine magnetic resonance (F-MR) imaging.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bjc.1996.9", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "73"
      }
    ], 
    "keywords": [
      "mumol kg-1", 
      "tumor response", 
      "tumor regression", 
      "EMT-6 tumor-bearing BALB/c mice", 
      "tumour-blood ratios", 
      "similar tumor growth delay", 
      "BALB/c mice", 
      "significant tumor response", 
      "tumor-bearing BALB/c mice", 
      "complete tumor regression", 
      "tumor growth delay", 
      "good tumor uptake", 
      "rapid blood clearance", 
      "magnetic resonance imaging", 
      "direct cell killing", 
      "Cremophor emulsion", 
      "serum concentrations", 
      "tumor volume", 
      "vascular stasis", 
      "complete occlusion", 
      "tumor uptake", 
      "blood clearance", 
      "neoplastic cells", 
      "growth delay", 
      "favorable pharmacokinetics", 
      "tumor vasculature", 
      "resonance imaging", 
      "dye administration", 
      "EMT-6 tumors", 
      "post injection", 
      "dye injection", 
      "pharmacokinetics", 
      "fluorine magnetic resonance imaging", 
      "dose", 
      "phototherapy", 
      "colony formation", 
      "clinical applications", 
      "cell killing", 
      "mice", 
      "kg-1", 
      "injection", 
      "days", 
      "regression", 
      "tumors", 
      "administration", 
      "response", 
      "clearance", 
      "occlusion", 
      "vasculature", 
      "high concentrations", 
      "drug formation", 
      "Photofrin", 
      "potential use", 
      "stasis", 
      "radiotracer", 
      "exposure", 
      "concentration", 
      "killing", 
      "imaging", 
      "cells", 
      "PDT", 
      "uptake", 
      "photodynamic properties", 
      "analogues", 
      "single isomeric product", 
      "control", 
      "volume", 
      "photosensitiser", 
      "use", 
      "acetate", 
      "delay", 
      "isolation", 
      "time", 
      "ratio", 
      "red light", 
      "potential", 
      "fluorinated dye", 
      "results", 
      "formation", 
      "dye", 
      "solubles", 
      "improved solubility", 
      "high potential", 
      "ZnPcF16", 
      "times lower efficiency", 
      "products", 
      "advantages", 
      "light", 
      "emulsions", 
      "low solubility", 
      "order", 
      "properties", 
      "salt", 
      "low efficiency", 
      "zinc acetate", 
      "zinc phthalocyanine", 
      "solubility", 
      "applications", 
      "tetrafluorophthalonitrile", 
      "ZnPc", 
      "pyridinium salts", 
      "condensation", 
      "efficiency", 
      "most common solvents", 
      "isomeric products", 
      "solvent", 
      "phthalocyanine", 
      "fluorine", 
      "dye concentration", 
      "fluorination", 
      "common solvents", 
      "most solvents", 
      "hydrogen atoms", 
      "atoms", 
      "condensation of tetrafluorophthalonitrile", 
      "ZnPc soluble", 
      "c mice", 
      "higher tumour-blood ratios", 
      "tumour dye concentrations", 
      "dose of ZnPc", 
      "drug level significant tumour response", 
      "level significant tumour response", 
      "vivo dye administration", 
      "magnitude higher potential", 
      "facilitated drug formation"
    ], 
    "name": "Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer", 
    "pagination": "49-53", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028994188"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1996.9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8554982"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1996.9", 
      "https://app.dimensions.ai/details/publication/pub.1028994188"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_275.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bjc.1996.9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1996.9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1996.9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1996.9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1996.9'


 

This table displays all metadata directly associated to this object as RDF triples.

278 TRIPLES      22 PREDICATES      169 URIs      156 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1996.9 schema:about N00a2748caba04958b04748ee57ef1331
2 N4b47f695e5f54e0b9dd08d48090673aa
3 N5a182bc4d6d248a3a944b1e00f62fc5f
4 N6330c66c8005489b85090dfe81a01f32
5 N63723bf24eb543ae8e33e238bb2bcfa9
6 N76e0d2ed25c4451b8924eaf0aa84aed2
7 N7ef418abbe2f439d9a3e35131bcdb2a3
8 N8690e488ab5c4248bf926a74448cbe07
9 N950b58b48a6345d09dd40fd1a0526152
10 Na8088e65da9d4b1096fe2eb8dba1162c
11 Nca7a8195634f41d29b64f21a24192ab6
12 Ncf5f0aee69e142ffaac65ae9d0bad154
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Nd3348f75b6ee4f64b79ca142c3542c8c
16 schema:citation sg:pub.10.1007/bf01002528
17 sg:pub.10.1038/279679a0
18 sg:pub.10.1038/bjc.1987.247
19 sg:pub.10.1038/bjc.1990.189
20 sg:pub.10.1038/bjc.1990.89
21 schema:datePublished 1996-01
22 schema:datePublishedReg 1996-01-01
23 schema:description Hexadecafluorinated zinc phthalocyanine (ZnPcF16), an analogue of zinc phthalocyanine (ZnPc) in which all hydrogen atoms have been substituted by fluorine, was prepared as a single isomeric product via the condensation of tetrafluorophthalonitrile with zinc acetate. Fluorination renders the ZnPc soluble in most common solvents. The photodynamic properties and pharmacokinetics of the ZnPcF16 were evaluated in EMT-6 tumour-bearing Balb/c mice using 65Zn-radiolabelled analogues. Both dyes, administered i.v. at 1 mumol kg-1 as Cremophor emulsions, revealed good tumour uptake [approximately 8-9 per cent of the injected dose per g tissue (%IDg-1)] at 24 h post injection (p.i.), with the fluorinated dye reaching higher concentrations (approximately 11%IDg-1) at 48 h p.i. and subsequently higher tumour-blood ratios due to rapid blood clearance. ZnPcF16 at a dose of 5 mumol kg-1 (4.3 mg kg-1) induced complete tumour regression after phototherapy (24 h p.i., 650-700 nm band, 360 J cm-2, 200 mW cm-1). At a dose of 2 mumol kg-1 and phototherapy at 24 h p.i., the tumour volume doubling time increased to 11 days vs 6 days for the control tumours. A similar tumour growth delay was observed when phototherapy was conducted at 48 h or 72 h after dye injection implying that tumour response correlates with tumour dye concentrations rather than serum concentrations. As a result of its low solubility, the administered dose of ZnPc was limited to 1 mumol kg-1 and at this drug level significant tumour response was only observed when the dye was solubilised as the pyridinium salt. Isolation of the neoplastic cells after in vivo dye administration and in vitro exposure to red light followed by a colony formation assay showed that the ZnPcF16 exhibited a 1-2 order of magnitude higher potential for direct cell killing as compared with Photofrin and about a five times lower efficiency than ZnPc. However, all three photosensitisers induced complete occlusion of tumour vasculature immediately after PDT, suggesting that tumour regression mainly resulted from vascular stasis. The ZnPcF16 offers several advantages over ZnPc for clinical applications, including improved solubility in most solvents, resulting in facilitated drug formation, favourable pharmacokinetics as well as the potential use in fluorine magnetic resonance (F-MR) imaging.
24 schema:genre article
25 schema:inLanguage en
26 schema:isAccessibleForFree true
27 schema:isPartOf N79b0099bdbbc4c0385242cd21b009ed5
28 Na8b2647bb37f4f958ad8c95bfe0627fb
29 sg:journal.1017082
30 schema:keywords BALB/c mice
31 Cremophor emulsion
32 EMT-6 tumor-bearing BALB/c mice
33 EMT-6 tumors
34 PDT
35 Photofrin
36 ZnPc
37 ZnPc soluble
38 ZnPcF16
39 acetate
40 administration
41 advantages
42 analogues
43 applications
44 atoms
45 blood clearance
46 c mice
47 cell killing
48 cells
49 clearance
50 clinical applications
51 colony formation
52 common solvents
53 complete occlusion
54 complete tumor regression
55 concentration
56 condensation
57 condensation of tetrafluorophthalonitrile
58 control
59 days
60 delay
61 direct cell killing
62 dose
63 dose of ZnPc
64 drug formation
65 drug level significant tumour response
66 dye
67 dye administration
68 dye concentration
69 dye injection
70 efficiency
71 emulsions
72 exposure
73 facilitated drug formation
74 favorable pharmacokinetics
75 fluorinated dye
76 fluorination
77 fluorine
78 fluorine magnetic resonance imaging
79 formation
80 good tumor uptake
81 growth delay
82 high concentrations
83 high potential
84 higher tumour-blood ratios
85 hydrogen atoms
86 imaging
87 improved solubility
88 injection
89 isolation
90 isomeric products
91 kg-1
92 killing
93 level significant tumour response
94 light
95 low efficiency
96 low solubility
97 magnetic resonance imaging
98 magnitude higher potential
99 mice
100 most common solvents
101 most solvents
102 mumol kg-1
103 neoplastic cells
104 occlusion
105 order
106 pharmacokinetics
107 photodynamic properties
108 photosensitiser
109 phototherapy
110 phthalocyanine
111 post injection
112 potential
113 potential use
114 products
115 properties
116 pyridinium salts
117 radiotracer
118 rapid blood clearance
119 ratio
120 red light
121 regression
122 resonance imaging
123 response
124 results
125 salt
126 serum concentrations
127 significant tumor response
128 similar tumor growth delay
129 single isomeric product
130 solubility
131 solubles
132 solvent
133 stasis
134 tetrafluorophthalonitrile
135 time
136 times lower efficiency
137 tumor growth delay
138 tumor regression
139 tumor response
140 tumor uptake
141 tumor vasculature
142 tumor volume
143 tumor-bearing BALB/c mice
144 tumors
145 tumour dye concentrations
146 tumour-blood ratios
147 uptake
148 use
149 vascular stasis
150 vasculature
151 vivo dye administration
152 volume
153 zinc acetate
154 zinc phthalocyanine
155 schema:name Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer
156 schema:pagination 49-53
157 schema:productId N7ab3d3d880a8475f94e8d76ea0447af0
158 N99c1c94e0ebf4a3ab570cccd48f5d0d0
159 Ne656e4b47aa844dea1679cbc03a00c01
160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028994188
161 https://doi.org/10.1038/bjc.1996.9
162 schema:sdDatePublished 2021-12-01T19:10
163 schema:sdLicense https://scigraph.springernature.com/explorer/license/
164 schema:sdPublisher N10929214035c461585536b96f81b1226
165 schema:url https://doi.org/10.1038/bjc.1996.9
166 sgo:license sg:explorer/license/
167 sgo:sdDataset articles
168 rdf:type schema:ScholarlyArticle
169 N00a2748caba04958b04748ee57ef1331 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Polyethylene Glycols
171 rdf:type schema:DefinedTerm
172 N03a43c0fcd764768ad51eebc4cd7c7cb rdf:first N3f683f1fd3f24709b2e1f5bae9f5d357
173 rdf:rest N8c03a39e760244c49da40c71fcec3da3
174 N10929214035c461585536b96f81b1226 schema:name Springer Nature - SN SciGraph project
175 rdf:type schema:Organization
176 N12be601b19914cd4999d66c69d9fa4de rdf:first sg:person.012347733603.90
177 rdf:rest N03a43c0fcd764768ad51eebc4cd7c7cb
178 N3f683f1fd3f24709b2e1f5bae9f5d357 schema:familyName Obochi
179 schema:givenName MOK
180 rdf:type schema:Person
181 N4b47f695e5f54e0b9dd08d48090673aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Organometallic Compounds
183 rdf:type schema:DefinedTerm
184 N5a182bc4d6d248a3a944b1e00f62fc5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Emulsions
186 rdf:type schema:DefinedTerm
187 N6330c66c8005489b85090dfe81a01f32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Tissue Distribution
189 rdf:type schema:DefinedTerm
190 N63723bf24eb543ae8e33e238bb2bcfa9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Animals
192 rdf:type schema:DefinedTerm
193 N76e0d2ed25c4451b8924eaf0aa84aed2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Zinc Radioisotopes
195 rdf:type schema:DefinedTerm
196 N79b0099bdbbc4c0385242cd21b009ed5 schema:volumeNumber 73
197 rdf:type schema:PublicationVolume
198 N7ab3d3d880a8475f94e8d76ea0447af0 schema:name doi
199 schema:value 10.1038/bjc.1996.9
200 rdf:type schema:PropertyValue
201 N7ef418abbe2f439d9a3e35131bcdb2a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Photochemotherapy
203 rdf:type schema:DefinedTerm
204 N8690e488ab5c4248bf926a74448cbe07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Indoles
206 rdf:type schema:DefinedTerm
207 N8c03a39e760244c49da40c71fcec3da3 rdf:first sg:person.0707506374.64
208 rdf:rest rdf:nil
209 N950b58b48a6345d09dd40fd1a0526152 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Mice
211 rdf:type schema:DefinedTerm
212 N99c1c94e0ebf4a3ab570cccd48f5d0d0 schema:name pubmed_id
213 schema:value 8554982
214 rdf:type schema:PropertyValue
215 N9d96bde4ff90459cb8254ce56da5904c rdf:first sg:person.01067576325.99
216 rdf:rest N12be601b19914cd4999d66c69d9fa4de
217 Na8088e65da9d4b1096fe2eb8dba1162c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Neoplasms, Experimental
219 rdf:type schema:DefinedTerm
220 Na8b2647bb37f4f958ad8c95bfe0627fb schema:issueNumber 1
221 rdf:type schema:PublicationIssue
222 Nca7a8195634f41d29b64f21a24192ab6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Mice, Inbred BALB C
224 rdf:type schema:DefinedTerm
225 Ncf5f0aee69e142ffaac65ae9d0bad154 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Photosensitizing Agents
227 rdf:type schema:DefinedTerm
228 Nd3348f75b6ee4f64b79ca142c3542c8c rdf:first sg:person.01270352613.45
229 rdf:rest N9d96bde4ff90459cb8254ce56da5904c
230 Ne656e4b47aa844dea1679cbc03a00c01 schema:name dimensions_id
231 schema:value pub.1028994188
232 rdf:type schema:PropertyValue
233 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
234 schema:name Medical and Health Sciences
235 rdf:type schema:DefinedTerm
236 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
237 schema:name Oncology and Carcinogenesis
238 rdf:type schema:DefinedTerm
239 sg:journal.1017082 schema:issn 0007-0920
240 1532-1827
241 schema:name British Journal of Cancer
242 schema:publisher Springer Nature
243 rdf:type schema:Periodical
244 sg:person.01067576325.99 schema:familyName Rousseau
245 schema:givenName J
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067576325.99
247 rdf:type schema:Person
248 sg:person.012347733603.90 schema:familyName Kudrevich
249 schema:givenName SV
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012347733603.90
251 rdf:type schema:Person
252 sg:person.01270352613.45 schema:affiliation grid-institutes:grid.86715.3d
253 schema:familyName Boyle
254 schema:givenName RW
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270352613.45
256 rdf:type schema:Person
257 sg:person.0707506374.64 schema:familyName van Lier
258 schema:givenName JE
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707506374.64
260 rdf:type schema:Person
261 sg:pub.10.1007/bf01002528 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010380021
262 https://doi.org/10.1007/bf01002528
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/279679a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047841974
265 https://doi.org/10.1038/279679a0
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/bjc.1987.247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052506826
268 https://doi.org/10.1038/bjc.1987.247
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/bjc.1990.189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050177334
271 https://doi.org/10.1038/bjc.1990.189
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/bjc.1990.89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015534457
274 https://doi.org/10.1038/bjc.1990.89
275 rdf:type schema:CreativeWork
276 grid-institutes:grid.86715.3d schema:alternateName MRC Group in the Radiation Sciences, Faculty of Medicine, Université de Sherbrooke, Québec, Canada
277 schema:name MRC Group in the Radiation Sciences, Faculty of Medicine, Université de Sherbrooke, Québec, Canada
278 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...